A detailed history of Fundamentun, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Fundamentun, LLC holds 30,696 shares of BMY stock, worth $1.63 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares
30,696
Previous 24,774 23.9%
Holding current value
$1.63 Million
Previous $1.03 Million 54.47%
% of portfolio
0.12%
Previous 0.09%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 17, 2024

BUY
$39.66 - $51.75 $234,866 - $306,463
5,922 Added 23.9%
30,696 $1.59 Million
Q2 2024

Jul 24, 2024

BUY
$40.25 - $52.99 $185,713 - $244,495
4,614 Added 22.89%
24,774 $1.03 Million
Q1 2024

Apr 16, 2024

BUY
$47.98 - $54.4 $120,861 - $137,033
2,519 Added 14.28%
20,160 $1.09 Million
Q4 2023

Jan 24, 2024

SELL
$48.48 - $57.85 $63,460 - $75,725
-1,309 Reduced 6.91%
17,641 $905,000
Q3 2023

Oct 24, 2023

BUY
$57.89 - $64.73 $152,655 - $170,693
2,637 Added 16.17%
18,950 $1.1 Million
Q2 2023

Jul 18, 2023

BUY
$63.71 - $70.74 $206,165 - $228,914
3,236 Added 24.75%
16,313 $1.04 Million
Q1 2023

May 01, 2023

BUY
$65.71 - $74.53 $76,617 - $86,901
1,166 Added 9.79%
13,077 $906,000
Q4 2022

Jan 19, 2023

SELL
$68.48 - $81.09 $410 - $486
-6 Reduced 0.05%
11,911 $0
Q3 2022

Oct 24, 2022

SELL
$0.13 - $76.84 $207 - $122,867
-1,599 Reduced 11.83%
11,917 $847,000
Q2 2022

Sep 06, 2022

SELL
$72.62 - $79.98 $32,533 - $35,831
-448 Reduced 3.21%
13,516 $1.04 Million
Q1 2022

Apr 26, 2022

BUY
$61.48 - $73.72 $110,725 - $132,769
1,801 Added 14.81%
13,964 $1.02 Million
Q4 2021

Jan 14, 2022

BUY
$53.63 - $62.52 $95,193 - $110,973
1,775 Added 17.09%
12,163 $758,000
Q3 2021

Oct 19, 2021

BUY
$59.17 - $69.31 $82,956 - $97,172
1,402 Added 15.6%
10,388 $615,000
Q2 2021

Jul 19, 2021

BUY
$61.91 - $67.42 $92,245 - $100,455
1,490 Added 19.88%
8,986 $600,000
Q1 2021

Apr 27, 2021

SELL
$59.34 - $66.74 $117,077 - $131,678
-1,973 Reduced 20.84%
7,496 $473,000
Q4 2020

Jan 29, 2021

BUY
$57.74 - $65.43 $56,007 - $63,467
970 Added 11.41%
9,469 $587,000
Q3 2020

Oct 29, 2020

BUY
$57.43 - $63.64 $97,631 - $108,188
1,700 Added 25.0%
8,499 $512,000
Q2 2020

Jul 28, 2020

BUY
$54.82 - $64.09 $110,078 - $128,692
2,008 Added 41.91%
6,799 $400,000
Q1 2020

May 04, 2020

BUY
$46.4 - $67.43 $222,302 - $323,057
4,791 New
4,791 $267,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $113B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Fundamentun, LLC Portfolio

Follow Fundamentun, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fundamentun, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fundamentun, LLC with notifications on news.